Identification of glutathione S-transferase pi as a protein involved in Parkinson disease progression.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  American Journal of Pathology

• Publication date

  2009-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2353/ajpath.2009.081019PMID 19498008PMCID PMC2708794
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mortalin: A Protein Associated With Progression of Parkinson Disease?

  2008cited by this paper
• 1-Methyl-4-phenylpyridinium affects fast axonal transport by activation of caspase and protein kinase C

  2007cited by this paper
• Glutathione S‐transferase polymorphisms and onset age in α‐synuclein A53T mutant Parkinson's disease

  2007cited by this paper
• GSTπ expression mediates dopaminergic neuron sensitivity in experimental parkinsonism

  2007cited by this paper
• Endoplasmic Reticulum Stress and Oxidative Stress: A Vicious Cycle or a Double-Edged Sword?

  2007cited by this paper
• Clinical diagnostic criteria for dementia associated with Parkinson's disease

  2007cited by this paper
• Activation of the unfolded protein response in Parkinson's disease.

  2007cited by this paper
• Redox in redux: Emergent roles for glutathione S-transferase P (GSTP) in regulation of cell signaling and S-glutathionylation.

  2007cited by this paper
• Inducible Alterations of Glutathione Levels in Adult Dopaminergic Midbrain Neurons Result in Nigrostriatal Degeneration

  2007cited by this paper
• Signal integration in the endoplasmic reticulum unfolded protein response

  2007cited by this paper
• Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force

  2007cited by this paper
• The Etiopathogenesis of Parkinson Disease and Suggestions for Future Research. Part II

  2007cited by this paper
• Differential effects of glutathione S-transferase pi (GSTP1) haplotypes on cell proliferation and apoptosis.

  2007cited by this paper
• Divergent mechanisms of paraquat, MPP+, and rotenone toxicity: oxidation of thioredoxin and caspase-3 activation.

  2007cited by this paper
• The Etiopathogenesis of Parkinson Disease and Suggestions for Future Research. Part I

  2007cited by this paper
• Proteomics Identification of Proteins in Human Cortex Using Multidimensional Separations and MALDI Tandem Mass Spectrometer*S

  2007cited by this paper
• Proteomic Identification of Novel Proteins in Cortical Lewy Bodies

  2007cited by this paper
• Association of A313 G polymorphism (GSTP1*B) in the glutathione‐S‐transferase P1 gene with sporadic Parkinson's disease

  2007cited by this paper
• Endoplasmic reticulum stress response in dendrites of cultured primary neurons.

  2007cited by this paper
• Myelin basic protein: a multifunctional protein

  2006cited by this paper
• Proteomic Identification of a Stress Protein, Mortalin/mthsp70/GRP75

  2006cited by this paper
• Challenges and Opportunities in Proteomics Data Analysis*

  2006cited by this paper
• Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the Consortium on DLB International Workshop

  2006cited by this paper
• α-Synuclein structure, posttranslational modification and alternative splicing as aggregation enhancers

  2006cited by this paper
• Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders

  2006cited by this paper
• Herbicide exposure modifies GSTP1 haplotype association to Parkinson onset age

  2006cited by this paper
• Lewy bodies.

  2006cited by this paper
• ER stress and neurodegenerative diseases

  2006cited by this paper
• Suppression of murine cerebral F2-isoprostanes and F4-neuroprostanes from excitotoxicity and innate immune response in vivo by α- or γ-tocopherol

  2005cited by this paper
• Phosphorylation of Neurogenin2 specifies the migration properties and the dendritic morphology of pyramidal neurons in the neocortex.

  2005cited by this paper
• Suppression of murine cerebral F2-isoprostanes and F4-neuroprostanes from excitotoxicity and innate immune response in vivo by alpha- or gamma-tocopherol.

  2005cited by this paper
• Aggregated α‐synuclein activates microglia: a process leading to disease progression in Parkinson's disease

  2005cited by this paper
• Molecular pathophysiology of Parkinson's disease.

  2005cited by this paper
• Glutathione transferases.

  2005cited by this paper
• Characterization of atrazine biotransformation by human and murine glutathione S-transferases.

  2004cited by this paper
• Case-only study of interactions between genetic polymorphisms of GSTM1, P1, T1 and Z1 and smoking in Parkinson's disease.

  2004cited by this paper
• A model for random sampling and estimation of relative protein abundance in shotgun proteomics.

  2004cited by this paper
• Analysis of α-Synuclein-associated Proteins by Quantitative Proteomics*[boxs]

  2004cited by this paper
• Analysis of alpha-synuclein-associated proteins by quantitative proteomics.

  2004cited by this paper
• BDNF Regulates the Translation of a Select Group of mRNAs by a Mammalian Target of Rapamycin-Phosphatidylinositol 3-Kinase-Dependent Pathway during Neuronal Development

  2004cited by this paper
• Proteasomal inhibition induced by manganese ethylene-bis-dithiocarbamate: relevance to Parkinson's disease.

  2004cited by this paper
• Modulation of Gene Expression by Cancer Chemopreventive Dithiolethiones through the Keap1-Nrf2 Pathway

  2003cited by this paper
• Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination

  2003cited by this paper
• Staging of brain pathology related to sporadic Parkinson's disease.

  2003cited by this paper
• Glutathione S-transferase M1, T1, and P1 polymorphisms and Parkinson's disease.

  2003cited by this paper
• Parkinsonian Mimetics Induce Aspects of Unfolded Protein Response in Death of Dopaminergic Neurons*

  2003cited by this paper
• Mechanism of Toxicity in Rotenone Models of Parkinson's Disease

  2003cited by this paper
• Endoplasmic Reticulum Stress and the Unfolded Protein Response in Cellular Models of Parkinson's Disease

  2002cited by this paper
• Endophilin-1: a multifunctional protein.

  2002cited by this paper
• An In Vitro Model of Parkinson's Disease: Linking Mitochondrial Impairment to Altered α-Synuclein Metabolism and Oxidative Damage

  2002cited by this paper
• An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin.

  2001cited by this paper
• Putative Transmembrane Polypeptide , which Can Lead to Endoplasmic Reticulum Stress , Is a Substrate of Parkin

  2001cited by this paper
• Catalytic efficiencies of allelic variants of human glutathione S-transferase Pi in the glutathione conjugation of α,β-unsaturated aldehydes

  2000cited by this paper
• Chronic systemic pesticide exposure reproduces features of Parkinson's disease

  2000cited by this paper
• Glial Fibrillary Acidic Protein: GFAP-Thirty-One Years (1969–2000)

  2000cited by this paper
• Catalytic efficiencies of allelic variants of human glutathione S-transferase Pi in the glutathione conjugation of alpha, beta-unsaturated aldehydes.

  2000cited by this paper
• Calcium signaling in the ER: its role in neuronal plasticity and neurodegenerative disorders.

  2000cited by this paper
• Regulation of JNK signaling by GSTp

  1999cited by this paper
• Diagnostic criteria for Parkinson disease.

  1999cited by this paper
• Presenilin-1 mutations downregulate the signalling pathway of the unfolded-protein response

  1999cited by this paper
• Parkinson's disease, pesticides, and glutathione transferase polymorphisms.

  1998cited by this paper
• The ubiquitin pathway in Parkinson's disease

  1998cited by this paper
• Parkinson's disease. First of two parts.

  1998cited by this paper
• Peroxynitrite and Hydrogen Peroxide Induced Cell Death in the NSC34 Neuroblastoma × Spinal Cord Cell Line: Role of Poly(ADP‐Ribose) Polymerase

  1998cited by this paper
• The CERAD neuropathology protocol and consensus recommendations for the postmortem diagnosis of Alzheimer's disease: a commentary.

  1997cited by this paper
• Myelin basic protein gene expression in neurons: developmental and regional changes in protein targeting within neuronal nuclei, cell bodies, and processes

  1996cited by this paper
• Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB)

  1996cited by this paper
• Protein Synthesis within Dendrites: Glycosylation of Newly Synthesized Proteins in Dendrites of Hippocampal Neurons in Culture

  1996cited by this paper
• Glutathione S-transferase isoenzymes in rat brain neurons and glia

  1993cited by this paper
• A Pi Form of Glutathione‐S‐Transferase Is a Myelin‐and Oligodendrocyte‐Associated Enzyme in Mouse Brain

  1991cited by this paper
• Glutathione S‐transferase in human brain

  1990cited by this paper
• Differential Localization of Glutathione‐S‐Transferase Yp and Yb Subunits in Oligodendrocytes and Astrocytes of Rat Brain

  1989cited by this paper
• Idiopathic Parkinson's disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients.

  1986cited by this paper
• Alzheimer's Disease: Clinical Features, Pathogenesis, and Treatment

  1984cited by this paper
• Parkinson's disease: A disorder due to nigral glutathione deficiency?

  1982cited by this paper
• The topographical distribution of S‐100 and GFA proteins in the adult rat brain: An immunohistochemical study using horseradish peroxidase‐labelled antibodies

  1976cited by this paper
• Bioinformatics Original Paper Improved Scoring of Functional Groups from Gene Expression Data by Decorrelating Go Graph Structure

  year unknowncited by this paper

• Modulation of Bromo- and Extra-Terminal Domain (BET) Proteins Exerts Neuroprotective Effects in Cell Culture Models of Parkinson’s Disease

  2026cites this paper
• Covalent inhibitors in Parkinson's disease: Molecular targeting strategies for neuroprotective intervention.

  2025cites this paper
• Multi-omics characterization of improved cognitive functions in Parkinson’s disease patients after the combined metabolic activator treatment: a randomized, double-blinded, placebo-controlled phase II trial

  2025cites this paper
• Detoxification and Age-Related Neurodegenerative Disease: Correlation and Therapeutic Potential.

  2025cites this paper
• Hydrogen activated the Nrf2/HO pathway to alleviate the cognitive decline in PD Drosophila after long-term sevoflurane exposure.

  2025cites this paper
• Glutathione S-transferase: A keystone in Parkinson's disease pathogenesis and therapy.

  2024cites this paper
• Overexpression of Glutathione S-Transferases in Human Diseases: Drug Targets and Therapeutic Implications

  2023cites this paper
• Tat-GSTpi Inhibits Dopaminergic Cells against MPP+-Induced Cellular Damage via the Reduction of Oxidative Stress and MAPK Activation

  2023cites this paper
• The Environmental Contribution to Redox Dyshomeostasis in Parkinson’s Disease

  2022cites this paper
• Antioxidant Genetic Profile Modifies Probability of Developing Neurological Sequelae in Long-COVID

  2022cites this paper
• Combined Metabolic Activators Improve Cognitive Functions without Altering Motor Scores in Parkinson's Disease

  2021cites this paper
• An Emerging Role for Phosphoinositides in the Pathophysiology of Parkinson’s Disease

  2021cites this paper
• Xenobiotic Transport and Metabolism in the Human Brain.

  2021cites this paper
• Dysfunction of Synaptic Vesicle Endocytosis in Parkinson’s Disease

  2021cites this paper
• Cerebrospinal fluid proteomics implicates the granin family in Parkinson’s disease

  2020cites this paper
• Mechanisms of synaptic vesicle recycling provide a platform to explore mechanisms of neurodegeneration

  2020cites this paper
• Biochemical Markers in Parkinson's Disease

  2020cites this paper
• Glutathione transferase Omega 1‐1 (GSTO1‐1) modulates Akt and MEK1/2 signaling in human neuroblastoma cell SH‐SY5Y

  2019cites this paper
• Phosphoproteomic and Kinomic Signature of Clinically Aggressive Grade I (1.5) Meningiomas Reveals RB1 Signaling as a Novel Mediator and Biomarker

  2019cites this paper
• Gait Analysis of Age-dependent Motor Impairments in Mice with Neurodegeneration.

  2018cites this paper
• Synaptic markers of cognitive decline in neurodegenerative diseases: a proteomic approach

  2018cites this paper
• Translational approaches to restoring mitochondrial function in Parkinson's disease

  2018cites this paper
• In Vitro Modulation of Redox and Metabolism Interplay at the Brain Vascular Endothelium: Genomic and Proteomic Profiles of Sulforaphane Activity

  2018cites this paper
• Inhibition of glutathione S-transferase-pi triggers c-jun N-terminal kinase-dependent neuronal death in Zn-induced Parkinsonism

  2018cites this paper
• Glutathione transferases: substrates, inihibitors and pro-drugs in cancer and neurodegenerative diseases

  2018cites this paper
• Genetic polymorphism of glutathione S-transferases: Relevance to neurological disorders.

  2018cites this paper
• Kinome and phosphoproteome of high-grade meningiomas reveal AKAP12 as a central regulator of aggressiveness and its possible role in progression

  2018cites this paper
• Presynaptic endocytic factors in autophagy and neurodegeneration.

  2018cites this paper
• Identification of the S-transferase like superfamily bacillithiol transferases encoded by Bacillus subtilis

  2018cites this paper
• Role of Glutathione-S-transferases in neurological problems

  2017cites this paper
• Immunotherapies for Movement Disorders: Parkinson’s Disease and Amyotrophic Lateral Sclerosis

  2017cites this paper
• Why should neuroscientists worry about iron? The emerging role of ferroptosis in the pathophysiology of neuroprogressive diseases

  2017cites this paper
• Human cytosolic glutathione-S-transferases: quantitative analysis of expression, comparative analysis of structures and inhibition strategies of isozymes involved in drug resistance

  2017cites this paper
• Inhibition of JNK by pi class of glutathione S-transferase through PKA/CREB pathway is associated with carnosic acid protection against 6-hydroxydopamine-induced apoptosis.

  2017cites this paper
• Endophilin-A Deficiency Induces the Foxo3a-Fbxo32 Network in the Brain and Causes Dysregulation of Autophagy and the Ubiquitin-Proteasome System

  2016cites this paper
• Protein biomarkers in Parkinson's disease: Focus on cerebrospinal fluid markers and synaptic proteins

  2016cites this paper
• Selenium in the Therapy of Neurological Diseases. Where is it Going?

  2016cites this paper
• S-Glutathionylation and Redox Protein Signaling in Drug Addiction.

  2016cites this paper
• Glutathione-Dependent Detoxification Processes in Astrocytes

  2015cites this paper
• Proteomic profiling in MPTP monkey model for early Parkinson disease biomarker discovery.

  2015cites this paper
• Glutathione transferases and neurodegenerative diseases.

  2015cites this paper
• Cerebrospinal Fluid Peptides as Potential Parkinson Disease Biomarkers: A Staged Pipeline for Discovery and Validation*

  2015cites this paper
• Chromosome-centric human proteome project: deciphering proteins associated with glioma and neurodegenerative disorders on chromosome 12.

  2014cites this paper
• Zebrafish brain proteomics reveals central proteins involved in neurodegeneration

  2014cites this paper
• Quantitative multiple reaction monitoring analysis of synaptic proteins from human brain.

  2014cites this paper
• Identification and characterization of molecular modulators of methylmercury-induced toxicity and dopamine neuron degeneration in Caenorhabditis elegans

  2014cites this paper
• noVel BIoMarKer CandIdates

  2014influential citation
• Excessive activation of the alternative complement pathway in autosomal dominant polycystic kidney disease

  2014cites this paper
• Proteomics as a new paradigm to tackle Parkinson’s disease research challenges

  2014cites this paper
• Induction of Pi form of glutathione S-transferase by carnosic acid is mediated through PI3K/Akt/NF-κB pathway and protects against neurotoxicity.

  2014cites this paper
• Toxicogenomic Studies of Human Neural Cells Following Exposure to Organophosphorus Chemical Warfare Nerve Agent VX

  2013cites this paper
• Glutathione metabolism and Parkinson's disease.

  2013cites this paper
• Chapter 86 – Parkinson’s Disease

  2013cites this paper
• Exposure to pesticides and heterozygote genotype of GSTP1-Alw26I are associated to Parkinson's disease.

  2013cites this paper
• The Nrf2/SKN-1-dependent glutathione S-transferase π homologue GST-1 inhibits dopamine neuron degeneration in a Caenorhabditis elegans model of manganism.

  2013cites this paper
• Estudo das alterações comportamentais e neuroquímicas da rotenona como um modelo animal de parkinsonismo

  2013cites this paper
• Alterations in Glutathione S-transferase pi expression following exposure to MPP+-induced oxidative stress in blood of Parkinson’s disease patients

  2013cites this paper
• Cerebrospinal fluid biomarkers of neuropathologically diagnosed Parkinson’s disease subjects

  2012cites this paper
• Electrophilic adduction of ubiquitin activating enzyme E1 by N,N-diethyldithiocarbamate inhibits ubiquitin activation and is accompanied by striatal injury in the rat.

  2012cites this paper
• Glutathione S-Transferase pi Mediates MPTP-Induced c-Jun N-Terminal Kinase Activation in the Nigrostriatal Pathway

  2012cites this paper
• Standardized extracts of Bacopa monniera protect against MPP+- and paraquat-induced toxicity by modulating mitochondrial activities, proteasomal functions, and redox pathways.

  2012cites this paper
• Exercise Does Not Protect against MPTP-Induced Neurotoxicity in BDNF Happloinsufficent Mice

  2012cites this paper
• Glutathione S-Transferase Omega 1 Activity Is Sufficient to Suppress Neurodegeneration in a Drosophila Model of Parkinson Disease*

  2012cites this paper
• Thiol-Redox Signaling, Dopaminergic Cell Death, and Parkinson's Disease

  2012cites this paper
• The Proteome of the Locus Ceruleus in Parkinson's Disease: Relevance to Pathogenesis

  2012influential citation
• Neurochemistry and the non-motor aspects of PD.

  2012cites this paper
• Proteomic analysis identifies dysfunction in cellular transport, energy, and protein metabolism in different brain regions of atypical frontotemporal lobar degeneration.

  2012cites this paper
• Proteomic analysis of glutathione S-transferase isoforms in mouse liver mitochondria.

  2012cites this paper
• Role of glutathione s-transferase pi in neuronal protection under oxidative stress and proteasome inhibition relevance to Parkinson’s disease

  2012cites this paper
• Mitochondrial Fusion/Fission, Transport and Autophagy in Parkinson's Disease: When Mitochondria Get Nasty

  2011cites this paper
• Glutathione‐S‐transferase P1 is a critical regulator of Cdk5 kinase activity

  2011cites this paper
• Méthodes de diagnostic

  2011cites this paper
• S-Glutathionylation: From Molecular Mechanisms to Health Outcomes

  2011cites this paper
• Alterations in glutathione S-transferase pi expression following exposure to MPP+ -induced oxidative stress in the blood of Parkinson's disease patients.

  2011cites this paper
• Cocaine-Induced Adaptations in Cellular Redox Balance Contributes to Enduring Behavioral Plasticity

  2011cites this paper
• Oxidative stress in zinc-induced dopaminergic neurodegeneration: Implications of superoxide dismutase and heme oxygenase-1

  2011cites this paper
• Quantitative analysis of human cerebrospinal fluid proteins using a combination of cysteine tagging and amine-reactive isobaric labeling.

  2011cites this paper
• Brain extracellular fluid protein changes in acute stroke patients.

  2011cites this paper
• Glutamatergic neuroplasticity in cocaine addiction.

  2011cites this paper
• Using ‘omics’ to define pathogenesis and biomarkers of Parkinson’s disease

  2010cites this paper
• Differential proteome of the striatum from hemiparkinsonian rats displays vivid structural remodeling processes.

  2010cites this paper
• Biomarkers for Cognitive Impairment in Parkinson Disease

  2010cites this paper
• Quantitative proteomic analysis of oligodendrogliomas with and without 1p/19q deletion.

  2010cites this paper
• Rapid Dopaminergic Modulation of the Fish Hypothalamic Transcriptome and Proteome

  2010cites this paper
• Proteomic analysis of dopamine and α‐synuclein interplay in a cellular model of Parkinson’s disease pathogenesis

  2010cites this paper